High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Summary statistics</td><td align="center"></td></tr><tr><td align="left"> Total observed</td><td align="center">63</td></tr><tr><td align="left"> Total failed</td><td align="center">24</td></tr><tr><td align="left"> Total censored</td><td align="center">39</td></tr><tr><td align="center" colspan="2"><hr/></td></tr><tr><td align="left">Quantiles estimation</td><td align="center"></td></tr><tr><td align="left"> Quantile</td><td align="center">50%</td></tr><tr><td align="left"> Estimate</td><td align="center"></td></tr><tr><td align="left"> Lower bound (95%)</td><td align="center">NA</td></tr><tr><td align="left"> Upper bound (95%)</td><td align="center">NA</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

International Scholarly Research Notices

tab4

Table 4

Table 4: High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables 

Table 4 | High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables 